Press Room
Archives
- Local surgeons are first with spinal device.
- Applied Spine Technologies reports Stabilimax NZ clinical trial milestone.
- Applied Spine Technologies completes $28 million 'Series C' financing
- Applied Spine Technologies receives CE Mark approval to market its Stabilimax NZ® and Stabilimax BAR® devices in Europe.
- FDA gives permission to AST to begin pivotal clinical trial!